US 9873692
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
granted A61PA61P1/00A61P1/04
Quick answer
US patent 9873692 (Quinolinone-carboxamide compounds as 5-HT4 receptor agonists) held by Theravance Biopharma R&D IP, LLC expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/10, A61P1/14